Additionally, established tumor markers such as CEA (carcinoembryonic antigen), ESM-1 (endothelial cell-specific molecule-1), and SCC (squamous cell carcinoma antigen) are not fully applicable for clinical diagnosis of OSCC due to their limited sensitivity and specificity (114, 115). Here, CEACAM5 is linked to neoplasm.